Liver transplantation from donors aged 80 years and over: pushing the limit

Am J Transplant. 2004 Jul;4(7):1139-47. doi: 10.1111/j.1600-6143.2004.00472.x.

Abstract

Older donors are a growing part of the total donor pool but no definite consensus exists on the limit of age for their acceptance. From November 1998 to January 2003, in a retrospective case-control multicenter study, we compared the outcome of 30 orthotopic liver transplantations (OLTs) with octogenarian donors and of 60 chronologically correlated OLTs performed with donors <40 years. The percentage of refusal was greater among older than younger donors (48.2 vs. 14.3%; p < 0.001). Cold ischemia was significantly shorter in the older than younger groups. Recipients with hepatocarcinoma and older age received octogenarian grafts more frequently. No differences were seen in post-operative complications and 6-month graft and patient survival. However, long-term survival was lower in patients transplanted with octogenarian donors (p = 0.04). Interestingly, the mortality related to hepatitis C recurrence was greater in patients with octogenarian donors. Accordingly, the long-term survival of HCV-positive patients who received older grafts was lower than those receiving younger grafts (p = 0.05). Octogenarian livers can be used safely but a careful donor evaluation and a short cold ischemia are required to prevent additional risk factors. However, hepatitis C recurrence is associated with a greater mortality in patients who received octogenarian grafts raising concerns whether to allocate these livers to HCV-positive recipients.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aging
  • Alanine Transaminase / blood
  • Aspartate Aminotransferases / blood
  • Bilirubin / blood
  • Case-Control Studies
  • Female
  • Follow-Up Studies
  • Graft Rejection
  • Graft Survival
  • Hepatitis C / metabolism
  • Hepatitis C / prevention & control
  • Hepatitis C / virology
  • Humans
  • Ischemia
  • Liver Neoplasms / metabolism
  • Liver Transplantation / methods*
  • Male
  • Middle Aged
  • Prothrombin / biosynthesis
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Tissue Donors*
  • Treatment Outcome

Substances

  • Prothrombin
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Bilirubin